Biofrontera (BFRI) shares jumped nearly 13% in recent Friday trading after the company raised $4.2 million from a private placement of a senior secured convertible note with its principal shareholders.
The three-year note bears a paid-in-kind annual interest of 10% and is secured by the company's assets, with the principal amount convertible into common shares at a fixed conversion price of $0.78 per share, the company said.
Biofrontera said it will use the proceeds to support its general operations and strategic investments, including its commercial and clinical development initiatives.
Price: 0.86, Change: +0.10, Percent Change: +12.78
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。